FIELD: medicine, pharmacology.
SUBSTANCE: medicinal preparation for benign prostatic hypertrophy, prostatitis, and alopecia treatment and/or prevention, obtained from green or mature fruits of king-palm tree (Roystonea regia), comprising mix of basic fatty acids with 8 to 18 carbon atoms, including the fatty acids, free acids and/or ethers, as follows: caprylic acid (C8:0), capric acid (C10:0), lauric acid (C12:0), myristic acid (C14:0), palmitic acid (C16:0), palmitoleic acid (C16:1), octadecanoic acid (C18:0), and oleic acid (C18:1), also including certain proportions of linoleic acid (C18:2) and linolenic acid (C18:3). Method of producing the medicinal preparation from fruits of king-palm tree (Roystonea regia) consists in fruits drying and grinding, basic hydrolysis either by alkaline/alkali-earth element hydroxide, or by ammonium hydroxide, extraction by 1-to-3-atomic alcohol or 5 to 8 hydrocarbon with heating and stirring, elimination of organic solvent, filtration and evaporation to dryness.
EFFECT: above described preparation is effective for benign prostatic hypertrophy and prostatitis treatment and prevention.
5 cl, 9 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CHEMOPROPHYLAXIS OF PROSTATE PRE-CANCER AND CANCER | 2012 |
|
RU2571818C2 |
| METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
| AGENT FOR REDUCING PATHOLOGICAL CHANGES IN PROSTATIC HYPERPLASIA | 2020 |
|
RU2740946C1 |
| COMPOSITION AND USING IT FOR HAIR GROWTH-STIMULATING EFFECT | 2009 |
|
RU2491914C2 |
| METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
| LOW-TOXIC 1,3,4-OXADIAZOLE DERIVATIVES OF DEOXYCHOLIC ACID WITH PROSTATE-PROTECTIVE AND ANTI-INFLAMMATORY ACTION | 2023 |
|
RU2819604C1 |
| USE OF COPAIFERA OLEORESINS IN PROSTATE PATHOLOGIES | 2018 |
|
RU2773173C2 |
| 1,2,4-OXADIAZOLE DERIVATIVES OF DESOXYCHOLIC ACID, EXHIBITING PROSTATE-PROTECTIVE EFFECT, HYPOCHOLESTEROLEMIC AND ANTI-INFLAMMATORY ACTIVITY | 2020 |
|
RU2750488C1 |
| MEANS AND METHOD OF CONDITIONS TREATMENT IMPLYING ANDROGEN ACTION DECREASE IS CONSIDERED TO BE FAVOURABLE, AND METHOD OF ANDROGEN-DEPENDENT TISSUE SENSITIVITY ITENSIFYING USING 9-OXOACRIDINE-10-ACETIC ACID | 2006 |
|
RU2328285C2 |
| COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF PROSTATE CANCER | 1998 |
|
RU2196582C2 |
